dept header
NYU Langone Home | Directory | Contact
   
Web People
 

PUBLICATIONS (Selected from 190)

Olarte J, Pérez-Pérez GI. Campylobacter jejuni in children with diarrhea in Mexico City. Pediatric Infect Dis 2:18-20, 1983.
 
Pérez-Pérez GI, Blaser MJ. Lipopolysaccharide characteristics of pathogenic campylobacters. Infect Immun 47:353-359, 1985.
 
Pérez-Pérez GI, Hopkins JA, Blaser MJ. Antigenic heterogeneity of lipopolysaccharides from Campylobacter jejuni and Campylobacter fetus. Infect Immun 48:528-533, 1985.
 
Pérez-Pérez GI, Hopkins JA, Blaser MJ. Lipopolysaccharide structures in Enterobacteriaceae, Pseudomonas aeruginosa and Vibrio cholerae immunologically related to Campylobacter. Infect Immun 51:204-208, 1986.
 
Pérez-Pérez GI, Blaser MJ, Bryner JH. Lipopolysaccharide structures of Campylobacter fetus related to heat-stable serogroups. Infect Immun 51:209-212, 1986.
 
Blaser MJ, Hopkins JA, Pérez-Pérez GI, Cody HJ, Newell DG. Antigenicity of Campylobacter jejuni flagella. Infect Immun 53:47-52, 1986.
 
Pérez-Pérez GI, Blaser MJ. Conservation and diversity of Campylobacter pyloridis major antigens. Infect Immun 55:1256-1263, 1987.
 
Pérez-Pérez GI, Dworkin BM, Chodos JE, Blaser MJ. Campylobacter pylori antibodies in humans. Ann Intern Med 109:11-17, 1988.
 
Pérez-Pérez GI, Cohn DL, Guerrant R, Patton CM, Reller LB, Blaser MJ. Clinical and immunological significance of cholera-like toxin and cytotoxin production by Campylobacter in patients with acute inflammatory diarrhea in the United States. J Infect Dis 160:460-468, 1989.
 
Dooley CP, Cohen H, Fitzgibbons PL, Bauer M, Appleman MD, Pérez-Pérez GI, Blaser MJ. Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med 321:1562-1566, 1989.
 
Drumm B, Pérez-Pérez GI, Blaser MJ, Sherman P. Intrafamilial clustering of Helicobacter pylori infection. N Engl J Med 322;359-363, 1990.
 
 Blaser MJ, Pérez-Pérez GI, Lindenbaum J, Schneidman D, Van Deventer G, Marin-Sorensen M., Weinstein WM. Association of Helicobacter pylori infection with specific upper gastrointestinal pathology. Rev Infect Dis 13(Suppl 8):S704-S708. 1991.
 
Pérez-Pérez GI, Witkin SS, Decker MD, Blaser, MJ. The seroprevalence of Helicobacter pylori infection in couples. J Clin Microbiol 29:642-644, 1991.
 
Fong TL, Dooley CP, Dehesa M, Cohen H, Carmel R, Fitzgibbons PL, Pérez-Pérez GI, Blaser MJ. Helicobacter pylori infection in pernicious anemia: a prospective controlled study. Gastroenterology 100:328-332, 1991.
 
 Parsonnet J, Blaser MJ, Pérez-Pérez GI, Hargrett-Beam N, Tauxe RV. Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists. Gastroenterol 102:41-46, 1992.
 
Pérez-Pérez GI, Marrie T, Inouye H. Shimoyama T, Marshall G, Meiklejohn G, Blaser MJ. Effect of age and occupation on the seroprevalence of Helicobacter pylori infection. Can J Infect Dis 3:134-138, 1992.
 
Nomura A, Stemmermann GN, Chyou P-H, Kato I, Pérez-Pérez GI, Blaser MJ. Helicobacter pylori infections and gastric carcinoma among Japanese-Americans in Hawaii. N Engl J Med 325:1132-1136, 1991.
 
Pérez-Pérez GI, Olivares AZ, Cover TL, Blaser MJ. Characteristics of Helicobacter pylori strains selected for urease deficiency. Infect Immun 60:3658-3663, 1992.
 
Pérez-Pérez GI, Taylor DN, Echeverria PD, Blaser MJ. Lack of evidence of enterotoxin involvement in pathogenesis of Campylobacter diarrhea. In: Nachamkin I, Blaser MJ and Tompkins LS (eds.) Campylobacter jejuni - current status and future trends. American Society for Microbiology, Washington, DC, pp 184-192, 1992.
 
Pérez-Pérez GI, Gower CB, Blaser MJ. Effects of cations on Helicobacter pylori urease activity, release, and stability. Infect Immun 62:299-302, 1994.
 
Pérez-Pérez GI, Brown WR, Dunn BD, Cover TL, Cao P, Blaser MJ. Correlation between gastric mucosal inflammation and serum immune responses in Helicobacter pylori infection. Clin Diagn  Lab Immunol 1:325-329,1994.
 
Pérez-Pérez GI, Shepherd VL, Morrow JD, Blaser MJ. Activation of human THP-1 cells and rat bone marrow-derived macrophages by Helicobacter pylori lipopolysaccharide.  Infect Immun  63:1183-1187, 1995.
 
Blaser MJ, Pérez-Pérez GI, Kleanthous H, Cover TL, Peek RM, Chyou PH, Stemmerman GH, Nomura A.  Infection with H. pylori strains possessing cagA associated with an increased risk of developing adenocarcinoma of the stomach.  Cancer Research 55:2111-2115, 1995.
 
Kuipers EJ, Pérez-Pérez GI, Meuwissen SGM, Blaser MJ.  Helicobacter pylori and atrophic gastritis: importance of the cagA status.  J Natl Cancer Inst 87:1777-1780, 1995.
 
Pérez-Pérez GI, Thiberge JM, Labigne A, Blaser MJ.  Relationship of immune response to heat-shock protein A and characteristics of Helicobacter pylori-infected patients.  J Infect Dis 174:1046-1050, 1996.
 
Pérez-Pérez GI, Bhat N, Gaensbauer J, Fraser A, Taylor DN, Kuipers EJ, Zhang L, You WC, Blaser MJ.  Country-specific constancy by age in cagA+ proportion of Helicobacter pylori infections.  Int J Cancer 72:453-456, 1997.
 
Pérez-Pérez GI.  Role of Helicobacter pylori infection in the development of Pernicious anemia.  Clin Infect Dis 25:1020-1022, 1997.
 
Pérez-Pérez GI, Cutler A, Blaser MJ.  Value of serology as a noninvasive method for evaluating the efficacy of treatment of Helicobacter pylori infection. Clin Infect Dis 25:1038-1043, 1997.
 
Torres J., Leal-Herrera Y, Pérez-Pérez GI, Gomez A, Camorlinga-Ponce M, Cedillo-Ribera R, Tapia-Conyer R, Muñoz O. A community-based seroepidemiological study of Helicobacter pylori infection in Mexico. J Infect Dis 178:1089-1094, 1998
 
Torres, J, Pérez-Pérez GI, Leal-Herrera Y, Muñoz O.  Infection with CagA+ Helicobacter pylori strains as a possible predictor of risk in the development of gastric adenocarcinoma in Mexico.  Int J Cancer 78:298-300, 1998.

Pérez-Pérez GI, Peek RM, Atherton JC, Blaser MJ, Cover TL.  Detection of serum and gastric juice anti-VacA antibody responses using type s1/m1 and s2/m2 Helicobacter pylori VacA antigens.  Clin Diagn Lab Immunol 6:489-493,1999.

Pérez-Pérez GI, Peek RM, Legath AJ, Heine PR, Graff LB.  The role of CagA status in gastric and extragastric complications of Helicobacter pylori.  J Physiol Pharmacol 1999; 50:833-845.
 
Vaezi MF, Falk GW, Peek RM, Vicari JJ, Goldblum JR, Pérez-Pérez GI, Rice TW, Blaser MJ, Richter JE. CagA-positive strains of Helicobacter pylori may protect against Barrett’s esophagus. Am J Gastroenterol 2000; 95:2206-2211.
 
Torres J, Pérez-Pérez GI, Goodman KJ, Atherton JC, Gold BD, Harris PR, Madrazo de la Garza A, Guarner J, Muñoz O. A comprehensive review of the natural history of Helicobacter pylori infection in children. Arch Med Res. 2000; 31:431-469.
 
Pérez-Pérez GI, Salomaa A, Kosunen TU, Daverman B, Rautelin H, Aromaa A, Knekt P, Blaser MJ. Evidence that cagA+ Helicobacter pylori strains are disappearing more rapidly than cagA-strains. Gut 2001; 50:295-298.
 
Nomura AMY, Pérez-Pérez GI, Lee J, Stemmermann G, Blaser MJ. Relationship between H. pylori cagA status and risk of peptic ulcer disease. Amer J Epidemiol 2002;155:1054-1059.
 
Nomura AMY, Lee J, Stemmermann GN, Nomura RY, Pérez-Pérez GI, Blaser MJ. Helicobacter pylori CagA seropositivity and gastric carcinoma risk in a Japanese American Population. J Infect Dis 2002;186:1138-1144.
 
Ghose C, Pérez-Pérez GI, Dominguez-Bello MG, Pride DT, Bravi C, Blaser MJ. East Asian genotypes of Helicobacter pylori strains in Amerindians provide evidence of its ancient human carriage. PNAS 2002;99:15107-15111.
 
Bosques-Padilla FJ, Tijerina-Menchaca R, Pérez-Pérez GI, Flores Gutierrez JP, Garza Gonzalez E. Prevalence of Helicobacter pylori in symptomatic patients in Northeastern Mexico and its association with disease. Arch Med Res 2003;34:60-63.
 
Falush D. Wirth T, Linz B, Pritchard J, Stephens M, Kidd M, Blaser MJ, Graham DY, Vacher S, Pérez-Pérez GI, Yamaoka Y, Megraud F, Otto K, Reichard U, Katzowitsch E, Wang X, Atchman M, Suerbaum S. Traces of human migrations in Helicobacter pylori populations. Science 2003;299:1582-1585.
 
Pérez-Pérez GI, Sack RB, Reid R, Santosham M, Croll J, Blaser MJ. Transient and persistent Helicobacter pylori colonization in Native American children. J Clin Microbiol. 2003;41:2401-2407.
 
Harris PR, Godoy A, Arenillas S, Riera F, Garcia D, Einisman H, Pena A, Rollan A, Duarte I, Guiraldes E, Pérez-Pérez G. CagA Antibodies as a Marker of  Virulence in Chilean Patients With Helicobacter pylori Infection. J Pediatr Gastroenterol Nutr. 2003;37:596-602.
 
Aspholm-Hurtig M, Dailide G, Lahmann M, Kalia A, Ilver D, Roche N, Vikstrom S, Sjostrom R, Linden S, Backstrom A, Lundberg C, Arnqvist A, Mahdavi J, Nilsson UJ, Velapatino B, Gilman RH, Gerhard M, Alarcon T, Lopez-Brea M, Nakazawa T, Fox JG, Correa P, Dominguez-Bello MG, Pérez-Pérez GI, Blaser MJ, Normark S, Carlstedt I, Oscarson S, Teneberg S, Berg DE, Boren T. Functional adaptation of BabA, the H. pylori ABO blood group antigen binding adhesin. Science. 2004;305(5683):519-22.
 
Pérez-Pérez GI, Rothenbacher D, Brenner H. Epidemiology of Helicobacter pylori infection. Helicobacter 2004;9:1-6.
 
Garza-Gonzalez E, Bosques-Padilla FJ, El-Omar E, Hola G, Tijerina-Menchaca R, Maldonado-Garza HJ, Pérez-Pérez GI. Role of polymorphic IL-1B, IL-1RN, and TNF-A genes in distal gastric cancer in Mexico. Int J Cancer. 2005;11:237-241.
 
Nomura AY, Kolonel LN, Miki K, Stemmermann GN, Wilkens LR, Goodman MT, Pérez-Pérez GI, Blaser MJ. Helicobacter pylori, pepsinogen and gastric adenocarcinoma. J Infect Dis, 2005;191:2075-2081.
 
Pérez-Pérez GI, Olivares AZ, Foo FY, Foo S, Neusy AJ, Ng C, Holzman RS, Marmor M, Blaser MJ. Seroprevalence of Helicobacter pylori in New York City populations originating in East Asia. J Urban Health, 2005;82:510-516
 
Franco AT, Israel DA, Washington Mk, Krishna U, Fox JG, Rogers AB, Neish AS, Collier-Hyams L, Pérez-Pérez GI, Hatakeyama M, Whitehead R, Gaus K, O’brien DP, Romero-Gallo J, Peek RMJr. Activation of {beta}-catenin by carcinogenic Helicobacter pylori. Proc Natl Acad Sci U S A. 2005;102:10646-10651.
 
Bhat N , Gaensbauer J , Peek RM , Bloch K , Blaser MJ , Pérez-Pérez G . Local and Systemic Immune and Inflammatory Responses to Helicobacter pylori Strains. Clin Diagn Lab Immunol. 2005;12:1393-1400.

Olivares A , Buadze M , Kutubidze T , Lobjanidze M , Labauri L , Kutubidze R , Chikviladze D , Zhvania M , Kharzeishvili O , Lomidze N , Pérez-Pérez GI . Prevalence of Helicobacter pylori in Georgian patients with dyspepsia. Helicobacter 2006, 11:81-85.
 
Blaser MJ, Nomura A, Lee J, Stemmerman GN, Pérez-Pérez GI. Early-life family structure and microbially induced cancer risk. PLoS Med 2007;4:53-58.
 
Francois F, Roper J, Goodman A, Pei Z, Ghumman M, Mourad M, Olivares AZ, Pérez-Pérez GI, Tseng CH, Blaser MJ. The association of gastrin leptin with esophageal inflammation and metaplasia. Gut 2008;57:16-24.
 
Romero-Gallo J, Harris EJ, Krishna U, Washington MK, Pérez-Pérez GI, Peek RM Jr. effect of Helicobacter pylori eradication on gastric carcinogenesis. Lab Invest 2008;88:328-336.
 
Epplein M, Nomura AM, Hankin JA, Blaser MJ, Pérez-Pérez GI, Stemmermann GN GN, Wilkens LR, Kolonel LN. Association of Helicobacter pylori infection and diet on the risk of gastric cancer, a case-control study in Hawaii. Cancer Causes Control 2008:19:869-877.
 
Sierra R, Une C, Ramirez V, Alpizar-Alpizar W, Gonzalez MI, Ramirez JA, De Mascarel A, Cuenca P, Pérez-Pérez G, Megraud F.  Relation of atrophic gastritis with Helicobacter pylori-CagA(+) and interleukin-1 gene polymorphisms.World J Gastroenterol. 2008;14:6481-7.
 
Reibman J, Marmor M, Filner J, Fernandez-Beros ME, Rogers L, Pérez-Pérez GI, Blaser MJ. Asthma is inversely associated with Helicobacter pylori status in an urban population. PLoS ONE. 2008;3:e4060. Epub 2008 Dec 29.
 

Books
Pérez-Pérez GI, Correa P, and Pajares JM, editors. Infeccion por Helicobacter pylori en lesiones gastro duodenales.  La segunda decada.  Prous Science, Barcelona, Spain, 1998, 1-314.
 

Invited Articles and Chapters

Blaser MJ, Pérez-Pérez GI. Characterization of xenoantibodies to Campylobacter species by immunoblotting: a model for other gram-negative bacteria. In: Bjerrum OJ, Heegaard NH (eds.) Handbook of immunoblotting of proteins. CRC Press, Boca Raton, Florida, 2:131-143, 1988.
 
Pérez-Pérez GI, Dunn BE. Diagnosis of Campylobacter pylori infection by serologic methods. In: Blaser MJ (ed.) Campylobacter pylori, in gastritis, and peptic ulcer disease. Igaku-Shoin, Inc. Medical Publishers, New York, NY., pp 163-174, 1989.
 
Pérez-Pérez GI, Blaser MJ. Campylobacter infections in human. In: Baron S and Jennings PM, (eds.) Medical Microbiology. Churchill Livingstone, Inc., New York, NY, pp 337-349, 1991.
  
Blaser MJ, Pérez-Pérez GI, Cover TL, Morris AL, Mai UEH, Smith PD. Chronic Helicobacter pylori infection of the stomach induces a persistent systemic humoral immune response. In: Tsuchiya M et al. (eds.). Frontiers of Mucosal Immunology Volume 1, Elsevier Science Publishers B.V., pp 685-688, 1991.
 
Morris AJ, Ali MR, Nicholson GI, Pérez-Pérez GI, Blaser MJ. Long-term follow-up of voluntary ingestion of Helicobacter pylori in Helicobacter pylori and gastroduodenal diseases. Vol. 3 IJI Publishing Co., LTD Tokyo, Japan, pp 1-9, 1991.
 
Pérez-Pérez GI, Parsonnet J. Epidemiology of Helicobacter pylori infections. O'Morain CA, O'Connor H.  Helicobacter pylori:  implications and practice.  Normed Verlag, Englewood, NJ, pp 52-57, 1994.
 
Pérez-Pérez GI. Helicobacter pylori. In: Enfemedades diarreicas del niño. Ediciones Medicas del Hospital Infantil. Mexico City, Mexico, pp 160-175, 1997
 
Pérez-Pérez Campylobacter. In: Giono S, Escobar GA, and Valdespino GJL (eds). Diagnostico de laboratorio de diarreas infectiosas.  Instituto Nacional de Diagnositico y Referencia Epidemiologicas, Secretaria de Salud Mexico, pp 281-294, 1994.
 
Pérez-Pérez GI, Blaser MJ. Campylobacter and Helicobacter.  In:  Baron S. (ed) Medical Microbiology. The University of Texas Medical Branch at Galveston, Galveston TX, 1996, PP 311-322.

Pérez-Pérez GI, Peña AS.  Serologia y respuesta inmunitaria humoral, sistemica y local. In: Pajares-Garcia JM, Correa P, Pérez-Pérez GI (eds) Infection por Helicobacter pylori en lesiones gastroduodenales.  La segunda decada. Prous Science, Barcelona, Spain, pp 73-81, 1998.

Pérez-Pérez GI.  Mecanismo de Patogenicidad de Helicobacter pylori. In: Pajares-Garcia JM, Correa P, Pérez-Pérez GI (eds) Infection por Helicobacter pylori en lesiones gastroduodenales.  La segunda decada. Prous Science, Barcelona, Spain, pp 107-115, 1998.

Pérez-Pérez GI Helicobacter buenos y malos In: Lopez-Brea M (ed) Helicobacter pylori Retos para el siglo XXI. Microbiologia, Clinica y Tratamiento. Prous Science, Barcelona, Spain pp31-40,1999.

Pérez-Pérez GI, Israel DA. Role of iron in Helicobacter pylori. Its influence in outer membrane protein expression and in pathogenicity. European J Gastroenterol Hepato. 2000;12:1263-1265.
 
Pérez-Pérez GI. Accurate diagnosis of Helicobacter pylori. Culture, including transport. Gastroenterology Clinics of NorthAmerica 2000; 29:879-884.

Pérez-Pérez GI. Is the association of Helicobacter pylori with humans a classical example of parasitism. Rev Gastroenterol Mex 2000; 65:7-12.

Pérez-Pérez GI. Vacuna para la infeccion por Helicobacter pylori? In: Boixeda de Miguel D, martin de Argila C (eds) Infeccion por Helicobacter pylori Mas alla del limite? Proas Science Barcelona Spain pp 461-470, 2001.

Pérez-Pérez GI. New era of Helicobacter pylori. Rev Gastrenterolo Mex 2005 70:31-32.

Pérez-Pérez GI. When and why should we eradicate the Helicobacter pylori. Rev Gastrenterolo Mex 2005 70:26-27.

Pérez-Pérez GI, Garza Gonzalez E, Portal C, Olivares AZ Role of Cytokine polymorphisms in the risk of distal gastric cancer development. Cancer Epidemiol Biomarkers Prev 2005;14:1869-1873.

Portal-Celhay C, Pérez-Pérez GI. Immune responses to Helicobacter pylori colonization: mechanisms and clinical outcomes. Clin Sci 2006;110:305-314.

Visit Our Labs

Lab Info